Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1445 Bush St
San Francisco, CA 94109Phone+1 415-972-4600Fax+1 415-975-0999
Education & Training
University of California (San Francisco)Residency, Ophthalmology, 1992 - 1995
Scripps Mercy HospitalInternship, Transitional Year, 1991 - 1992
Johns Hopkins University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - 2025
NY State Medical License 2001 - 2006- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 48 citationsThe Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.Aniruddha Agarwal, Rupesh Agrawal, Dinesh Visva Gunasekaran, Dhananjay Raje, Bhaskar Gupta
Ocular Immunology and Inflammation. 2019-04-03 - 976 citationsPegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseEugene W. M. Ng, David T. Shima, Perry Calias, Emmett T. Cunningham, David R. Guyer
Nature Reviews. Drug Discovery. 2006-02-01 - 189 citationsYear 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.U Chakravarthy, Anthony P. Adamis, Emmett T. Cunningham, Michael H. Goldbaum, David R. Guyer
Ophthalmology. 2006-07-07
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
